The diagnosis rate of aortic stenosis is still low in China compared with its population size.

与中国的人口规模相比，主动脉狭窄的诊断率仍然很低。

In 2020, the company's transcatheter aortic valve system — Sapien 3 — was approved in China as the first such system imported by the country to help patients with aortic stenosis improve their prognosis and quality of life.

2020年，该公司的经导管主动脉瓣系统Sapien 3在中国获批，成为中国进口的第一个此类系统，帮助主动脉狭窄患者改善预后和生活质量。